Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.

Authors

Elizabeth A. Magnuson
Khaja Chinnakondepalli
Katherine Vilain
Clive Kearon
Jim A. Julian
Susan R. Kahn
Samuel Z. Goldhaber
Michael R. Jaff
Andrei L. Kindzelski
Kevin Herman
Paul S. Brady
Karun Sharma, George Washington University
Carl M. Black
Suresh Vedantham
David J. Cohen

Document Type

Journal Article

Publication Date

10-8-2019

Journal

Circulation: Cardiovascular Quality and Outcomes

Volume

12

Issue

10

Inclusive Pages

005659

DOI

10.1161/CIRCOUTCOMES.119.005659

Comments

Epub 2019 Oct 8

APA Citation

Magnuson, E. A., Chinnakondepalli, K., Vilain, K., Kearon, C., Julian, J. A., Kahn, S. R., Goldhaber, S. Z., Jaff, M. R., Kindzelski, A. L., Herman, K., Brady, P. S., Sharma, K., Black, C. M., Vedantham, S., & Cohen, D. J. (2019). Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.. Circulation: Cardiovascular Quality and Outcomes, 12 (10). http://dx.doi.org/10.1161/CIRCOUTCOMES.119.005659

Peer Reviewed

1